Serological activity against galactosyl-alpha(1-3)galactose in sera from patients with several kinetoplastida infections.
Using rabbit erythrocyte-derived neutral glycosphingolipids enriched for a defined ceramide pentasaccharide as antigens, we have detected elevated anti-galactosyl-alpha(1-3)galactose (anti-G alpha G) antibody values in patients with American cutaneous leishmaniasis (ACL), chronic Chagas' disease, and Trypanosoma rangeli infections compared with normal subjects or with patients suffering from any of 15 other infectious diseases. The specificity of the G alpha G antibodies was determined by inhibition enzyme-linked immunosorbent assays, which revealed that several alpha-galactosyl- but not beta-galactosyl-bearing sugars blocked absorption of G alpha G antibodies to the specific antigen used. G alpha G antibodies were mainly distributed between immunoglobulin classes G and M in three Kinetoplastida infections studied, with a lower increase in reactivity detected in immunoglobulin A. Absorption of highly reactive G alpha G antibodies with purified murine laminin and nidogen, two basement membrane proteins, almost abolished G alpha G reactivity, suggesting the identity of anti-G alpha G with laminin and nidogen antibodies previously reported as elevated in Kinetoplastida infections. In ACL, G alpha G antibodies were detected in 71% of patients having skin lesions with a clinical evolution time of 0.5 month. This percentage increased with the time of evolution of skin lesions, reaching 93% in lesions older than 3 months, and tended to decrease inversely to the induration diameter in the skin leishmanin test. It is proposed that similar epitopes may exist on kinetoplast protozoa and that the determination of G alpha G antibodies may be a highly sensitive assay for the detection of humoral responses to Kinetoplastida infections.
D000017:ABO Blood-Group System; D000906:Antibodies / Q000032:analysis; D000913:Antibodies, Protozoan / Q000032:analysis*; D000918:Antibody Specificity; D014355:Chagas Disease / Q000276:immunology*; D003429:Cross Reactions; D004187:Disaccharides / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D007797:Laminin / Q000276:immunology; D007896:Leishmaniasis / Q000276:immunology*; D008562:Membrane Glycoproteins; D008565:Membrane Proteins / Q000276:immunology; D014352:Trypanosomiasis / Q000276:immunology*
D000017:ABO Blood-Group System; D000906:Antibodies; D000913:Antibodies, Protozoan; D004187:Disaccharides; D000939:Epitopes; D007797:Laminin; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; C029967:nidogen; C055075:galactosyl-(1-3)galactose